Aisling Capital Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Hold
2,048,757
0.64% 9
2026
Q1
$3.13M Hold
2,048,757
0.66% 8
2025
Q4
$2.54M Hold
2,048,757
0.53% 9
2025
Q3
$4.14M Hold
2,048,757
0.91% 9
2025
Q2
$3.69M Buy
2,048,757
+1,250,000
+156% +$2.41M 1.03% 7
2025
Q1
$1.7M Hold
798,757
0.59% 8
2024
Q4
$3.1M Hold
798,757
1.1% 9
2024
Q3
$8.07M Hold
798,757
3.09% 5
2024
Q2
$3.59M Hold
798,757
1.56% 8
2024
Q1
$11.9M Hold
798,757
4.04% 5
2023
Q4
$11.6M Hold
798,757
3.46% 4
2023
Q3
$11M Hold
798,757
4.53% 4
2023
Q2
$17.5M Hold
798,757
8.59% 4
2023
Q1
$24.8M Hold
798,757
11.92% 2
2022
Q4
$6.73M Hold
798,757
4.45% 6
2022
Q3
$7.81M Hold
798,757
5.19% 6
2022
Q2
$9.57M Hold
798,757
6.83% 4
2022
Q1
$3.56M Hold
798,757
1.92% 12
2021
Q4
$5.95M Hold
798,757
2.1% 13
2021
Q3
$9.56M Hold
798,757
1.91% 9
2021
Q2
$12.5M Buy
+798,757
New +$14.1M 2% 8

Other funds holding BMEA

Aisling Capital Management's BMEA Position: Q2 2026 in Review

Aisling Capital Management held its Biomea Fusion (BMEA) position steady in Q2 2026 at 2,048,757 shares worth $3.01M. The position accounts for 0.64% of the portfolio, ranked #9.

Aisling Capital Management first reported a position in BMEA in Q2 2021 and has held it in 21 quarters since. The position peaked at $24.8M in Q1 2023. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Aisling Capital Management held 2,048,757 shares of Biomea Fusion worth $3.01M as of Q2 2026.
  • Aisling Capital Management left its Biomea Fusion share count unchanged in Q2 2026.
  • Biomea Fusion made up 0.64% of Aisling Capital Management's portfolio in Q2 2026, its #9 holding.
  • Aisling Capital Management first reported a position in Biomea Fusion in Q2 2021 and has held it in 21 quarters since.
  • Aisling Capital Management's Biomea Fusion position peaked at $24.8M in Q1 2023.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Aisling Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.